Form 4: Tenet Healthcare CEO Saumya Sutaria Sells Shares
SEC Form 4 Filing
Tenet Healthcare's Chairman and CEO, Saumya Sutaria, recently sold shares of the company's common stock.
Summary
- On August 14 and 15, 2024, Saumya Sutaria, Chairman & CEO of Tenet Healthcare Corp, sold shares of common stock.
- On August 14, 2024, Sutaria sold 81,098 shares at a weighted average price of $154.35, with individual prices ranging from $154.00 to $154.99.
- Also on August 14, 2024, Sutaria sold 5,129 shares at a weighted average price of $155.4, with individual prices ranging from $155.00 to $155.72.
- On August 15, 2024, Sutaria sold 12,241 shares at a weighted average price of $154.5, with individual prices ranging from $154.00 to $154.99.
- Additionally, on August 15, 2024, Sutaria sold 1,532 shares at a weighted average price of $155.36, with individual prices ranging from $155.00 to $155.96.
- Following these transactions, Sutaria directly owns 271,521 shares of Tenet Healthcare common stock.
- His wife indirectly owns 0 shares of Tenet Healthcare common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating stock sales by an executive. It doesn't inherently convey positive or negative sentiment, but the market's reaction to the news could vary.
Risks
- Executive stock sales can sometimes be perceived negatively by investors, potentially leading to short-term stock price volatility.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies. The reasons for such sales can vary widely, from personal financial planning to diversification strategies. It's important to consider the overall context of the company's performance and industry trends when interpreting these transactions.
Stakeholder Impact
- Shareholders may react to the stock sale, potentially influencing the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Saumya Sutaria sold shares of common stock. |
| 08/15/2024 | Saumya Sutaria sold shares of common stock. |
| 08/16/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.